Residency · Residency · General Surgery

Necrotizing Soft Tissue Infections

Introduction

Necrotizing soft tissue infections (NSTIs) are rapidly progressive, life-threatening infections characterized by widespread necrosis of the fascia, subcutaneous tissue, and occasionally muscle. Mortality rates range from 20-40% even with aggressive treatment. Early recognition, immediate broad-spectrum antibiotics, and emergent surgical debridement are the pillars of management. Delay in operative intervention is the single most important modifiable factor associated with mortality.

Classification

Type I (polymicrobial/synergistic) infections are the most common type, accounting for 70-80% of cases. They are caused by a mixture of aerobic and anaerobic organisms and typically occur in patients with diabetes, peripheral vascular disease, or immunosuppression, commonly affecting the trunk, perineum, and abdominal wall. Type II (monomicrobial) infections are caused by a single organism, most commonly Group A Streptococcus or Staphylococcus aureus (including MRSA), and can occur in young, healthy individuals, with the extremities being the most common location. Type III (gas gangrene/clostridial myonecrosis) is caused by Clostridium perfringens or other clostridial species, is associated with traumatic wounds (particularly soil-contaminated injuries), and produces gas in tissues with rapidly progressive myonecrosis. Type IV (fungal) infections are rare, caused by Candida or Zygomycetes, and occur in severely immunocompromised patients or after traumatic injuries in immunocompetent hosts.

Specific Clinical Entities

Fournier gangrene is necrotizing fasciitis of the perineum and genitalia, originating from anorectal, urogenital, or cutaneous sources, and carries higher mortality than extremity NSTI. Ludwig angina is a rapidly progressive cellulitis of the submandibular space with risk of airway compromise. Cervical necrotizing fasciitis is often odontogenic in origin and can spread to the mediastinum.

Microbiology

Type I organisms include Escherichia coli, Bacteroides fragilis, Peptostreptococcus, Clostridium species, Klebsiella, Proteus, and Enterococcus. Type II organisms include Group A Streptococcus (which produces M protein, streptolysin, and superantigens) and MRSA (Panton-Valentine leukocidin-producing strains). Vibrio vulnificus is associated with saltwater exposure and raw shellfish consumption and is rapidly fatal in patients with liver disease or iron overload states. Aeromonas hydrophila is associated with freshwater exposure and has a similar clinical presentation to Vibrio.

<image>Cross-sectional anatomical diagram showing the tissue planes involved in necrotizing soft tissue infection, with labels for skin, subcutaneous fat, superficial fascia, deep investing fascia, and muscle compartment, illustrating the pattern of spread along fascial planes with thrombosis of perforating vessels</image>

Risk Factors

Diabetes mellitus is the most common comorbidity, present in 40-60% of cases. Obesity and peripheral vascular disease are additional risk factors. Immunosuppression from HIV, chronic steroid use, chemotherapy, or organ transplantation increases susceptibility, as do chronic kidney disease and liver cirrhosis. Intravenous drug use, particularly with subcutaneous "skin popping," is a recognized risk factor. Recent surgery or trauma, including minor skin breaks, can serve as a portal of entry. NSAIDs may mask early signs and potentially promote Group A Streptococcus NSTI progression.

Clinical Presentation and Diagnosis

Early signs in the first 24-48 hours include pain out of proportion to physical findings, erythema without clear borders, edema and induration, fever, and tachycardia. Intermediate signs include skin color changes (dusky, violaceous), bullae or hemorrhagic blisters, and crepitus on palpation (present in only 15-30% of cases). Late signs include cutaneous anesthesia from nerve destruction, frank skin necrosis, hemodynamic instability, septic shock, and multiorgan failure. Laboratory findings include leukocytosis (WBC above 15,000) or leukopenia, elevated CRP and lactate, hyponatremia (sodium below 135), elevated creatinine, and coagulopathy. The LRINEC score (Laboratory Risk Indicator for Necrotizing Fasciitis), incorporating CRP, WBC, hemoglobin, sodium, creatinine, and glucose, has a sensitivity of 68-90% at a score of 6 or greater, but it should never delay surgical exploration if clinical suspicion is high.

Imaging

CT with intravenous contrast is the most useful imaging modality, with findings including fascial thickening and enhancement, gas tracking along fascial planes, fluid collections, and fat stranding, with sensitivity of 80-90%. MRI provides superior soft tissue detail but is too time-consuming for unstable patients. Plain radiographs may show subcutaneous gas but have low sensitivity. The critical principle is that imaging should never delay surgical exploration when clinical suspicion is high, as NSTI remains a clinical and surgical diagnosis.

<image>CT scan of the lower extremity showing necrotizing soft tissue infection with subcutaneous gas tracking along the fascial planes, fascial thickening with enhancement, and surrounding inflammatory fat stranding, with arrows indicating key diagnostic findings</image>

Surgical Management

Emergent surgical debridement is the definitive treatment and should not be delayed. Operative findings include dishwater-gray necrotic fascia, lack of bleeding at the fascial level, lack of tissue resistance to blunt dissection (positive "finger test"), and foul-smelling discharge. All necrotic tissue must be excised until healthy, bleeding tissue is encountered in all directions, and debridement should extend beyond the visible margins of infection. Tissue cultures (more reliable than wound swabs) and tissue for histopathology should be obtained. The wound is left open, and vacuum-assisted closure may be applied after adequate debridement. Planned re-exploration at 24-48 hours is mandatory to assess for progression and perform additional debridement, and an average of 3-4 debridements are typically required. A diverting colostomy may be necessary in Fournier gangrene to protect perineal wounds. Orchiectomy is rarely needed in Fournier gangrene because the testes have an independent blood supply.

Antimicrobial Therapy

Empiric broad-spectrum therapy should be initiated immediately and includes vancomycin or linezolid for MRSA coverage, piperacillin-tazobactam or a carbapenem for broad gram-negative and anaerobic coverage, and clindamycin to inhibit toxin production (particularly streptococcal superantigens and clostridial toxins). Antibiotics are narrowed based on culture results and continued until no further debridements are needed, systemic signs resolve, and the wound is clean.

Supportive Care and Adjuncts

Aggressive fluid resuscitation and vasopressor support are provided as needed. ICU admission is required for hemodynamic monitoring and organ support. Nutritional support with early enteral nutrition is important, as patients often have massive caloric requirements. Hyperbaric oxygen therapy is controversial and may be considered as an adjunct but should never delay surgery, and evidence for a mortality benefit is limited. Intravenous immunoglobulin may be considered for streptococcal toxic shock syndrome to neutralize superantigens, though evidence is mixed.

Wound Reconstruction

After source control is achieved and the wound is clean, reconstruction options include secondary intention for small wounds, split-thickness skin grafting for large surface area defects, local or free tissue flaps for complex wounds with exposed critical structures, and testicular transposition into medial thigh pouches for scrotal loss in Fournier gangrene.

<image>Intraoperative photograph illustration of necrotizing fasciitis debridement showing the characteristic dishwater-gray necrotic fascia being separated from the overlying skin and underlying muscle with blunt dissection, with surrounding viable tissue margins marked</image>

Key Clinical Pearls

Pain out of proportion to exam findings is the earliest and most important clinical clue to necrotizing soft tissue infection. NSTI is a surgical emergency, and imaging and laboratory scoring systems should never delay operative exploration. Clindamycin should be included in the antibiotic regimen for its antitoxin properties. Re-exploration at 24-48 hours should be planned, as most patients require multiple debridements. Mortality doubles with each hour of delay in surgical intervention beyond the first 12 hours of presentation.

References

1. Stevens DL, Bisno AL, Chambers HF, et al. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the IDSA. Clin Infect Dis. 2014;59(2):e10-e52.
2. Wong CH, Khin LW, Heng KS, et al. The LRINEC (Laboratory Risk Indicator for Necrotizing Fasciitis) score: a tool for distinguishing necrotizing fasciitis from other soft tissue infections. Crit Care Med. 2004;32(7):1535-1541.
3. Sartelli M, Guirao X, Hardcastle TC, et al. 2018 WSES/SIS-E consensus conference: recommendations for the management of skin and soft-tissue infections. World J Emerg Surg. 2018;13:58.
4. Anaya DA, Dellinger EP. Necrotizing soft-tissue infection: diagnosis and management. Clin Infect Dis. 2007;44(5):705-710.

Read this lecture as Markdown